Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 190

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1B
Chunk 190
---
-1 filed July 28, 2023).
  
    10.8+
     
    Amendment
    to Employment Agreement, August 28, 2023, between MIRA Pharmaceuticals, Inc. and Erez Aminov (incorporated by reference to Exhibit
    10.1 to the Current Report on Form 8-K filed August 31, 2023).
  
    10.9+
     
    Employment
    Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Michelle Yanez (incorporated by reference to Exhibit 10.8
    to Form S-1 filed July 28, 2023).
  
    10.10
     
    Promissory
    Note and Loan Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Bay Shore Trust (incorporated by reference
    to Exhibit 10.10 to Form S-1 filed July 28, 2023).
  
    10.11
     
    Registration
    Rights Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Bay Shore Trust (incorporated by reference to Exhibit
    10.11 to Form S-1 filed July 28, 2023).
  
    10.12
     
    Agreement
    for Shared Lease Costs, dated April 1, 2023, between MIRA Pharmaceuticals, Inc., Telomir Pharmaceuticals, Inc., and MIRALOGX LLC
    (incorporated by reference to Exhibit 10.12 to Form S-1 filed July 28, 2023).

86

    10.13
     
    Exclusive
    License Agreement, by and between the Company and MIRALOGX, dated as of November 30, 2023 (incorporated by reference to Exhibit 10.1
    to the Current Report on Form 8-K filed November 20, 2023).
  
    10.14
     
    Promissory
    Note and Loan Agreement, by and between the Company and MIRALOGX, dated as of November 15, 2023 (incorporated by reference to Exhibit
    10.3 to the Current Report on Form 8-K filed November 20, 2023).
  
    10.15
     
    Amended and Rest